Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 498 shares at $114.81 ($57K) on 2015-12-22, disclosed to the SEC on 2015-12-24.
Scheduled sale ($57k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |